Beam Therapeutics Inc. Stock Performance

Open $24.32	Prev. Close $24.79	Circuit Range N/A
Day Range $23.94 - $24.68	Year Range $20.23 - $38.16	Volume 67,776
Average Traded $24.34

Beam Therapeutics Inc. Share Price Today

As of 9 October 2026, Beam Therapeutics Inc.'s share price is $24.58. The stock opened at $24.32, compared to its previous close of $24.79. During today's trading session, Beam Therapeutics Inc.'s share price traded between $23.94 and $24.68, with an average price of $24.31. Over the past 52 weeks, the stock has recorded a high of $38.16 and a low of $20.23. In terms of performance, Beam Therapeutics Inc.'s share price has declined by 18.90% over the last six months and is down 1.72% on a year-on-year basis.

Beam Therapeutics Inc. Share Price Chart

$23.94$24.68

Beam Therapeutics Inc. Stock Fundamentals & Key Indicators

Market Cap $2.43B	PE Ratio (TTM) N/A	Dividend Yield 0.00%
EPS (TTM) $-0.83	Revenue (TTM) $139.74B	Return On Equity (TTM) -8.00%
Profit Margin -57.24%	Debt to Equity 0.09	Quarterly Earnings Growth YoY -8.83%

Beam Therapeutics Inc. Quarterly Profit & Loss

All figures in USD

Particulars	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	$9.70	$114.11	$31.74	$0.49
Net Profit	-$112.73	$244.30	-$94.32	-$122.68
Net Profit Margin	-1162.16%	214.09%	-297.16%	-25036.73%
Income Change	N/A	316.71%	-138.61%	-30.07%

Beam Therapeutics Inc. Annual Profit & Loss

All figures in USD

Particulars	2022	2023	2024	2025
Revenue	$60.92	$377.71	$63.52	$139.74
Net Profit	-$289.09	-$132.53	-$376.74	-$79.99
Net Profit Margin	-474.54%	-35.09%	-593.10%	-57.24%
Income Change	N/A	54.16%	-184.27%	78.77%

About Beam Therapeutics Inc.

Beam Therapeutics Inc is a biotechnology company committed to creating a new class of precision genetic medicines based on its proprietary base editing technology, with a vision of providing lifelong cures to patients suffering from serious diseases. The company is focused on its programs in the hematology and genetic disease portfolios, which comprise different product candidates in its pipeline, such as BEAM-101, which is being developed to target Sickle Cell Disease, BEAM-302, a liver-targeting lipid nanoparticle, being developed to target Alpha-1 antitrypsin deficiency, and other drug candidates including BEAM-302, BEAM-103 & 104. The company operates and manages its business in one operating segment, United States.

Beam Therapeutics Inc. Historical Returns

Month	Open	Close	Change %
Oct 2026	$23.97	$24.62	+0.53%
Sep 2026	$29.02	$24.49	-19.55%
Aug 2026	$25.55	$30.44	+19.42%
Jul 2026	$34.67	$25.49	-25.69%
Jun 2026	$32.31	$34.30	+4.13%
May 2026	$29.93	$32.94	+8.68%
Apr 2026	$24.35	$30.31	+27.27%
Mar 2026	$27.50	$23.82	-16.38%
Feb 2026	$27.24	$28.48	+3.15%
Jan 2026	$27.63	$27.61	-0.36%
Dec 2025	$24.91	$27.71	+9.37%
Nov 2025	$24.98	$25.34	+1.30%

BEAM Share Price FAQs

What is Beam Therapeutics Inc. share price today?

Beam Therapeutics Inc. share price today is $24.58 as on October 9, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Beam Therapeutics Inc. stock?

The 52 week high of Beam Therapeutics Inc. stock is $38.16, while the 52 week low is $20.23 as of 9 Oct '26.

What is BEAM's market capitalisation today?

BEAM market capitalisation is $2.43B as of October 9, 2026, at 2:58 pm IST.

What is BEAM's net income for the last quarter?

BEAM's net income for the last quarter is -122.68B USD.

What is the 5 year returns of BEAM?

The 5 year returns of BEAM is -72.29% as on 9 Oct '26.

What is the high & low stock price of BEAM today?

BEAM stock price hit a high of $24.68 and low of $23.94 as of 9 Oct '26.

Can I buy BEAM shares in India?

Yes. You can buy BEAM in India by opening an international trading account.